By proceeding, you agree to our Terms of Use and Privacy Policy.
The 6th Microbiome Movement - Skin Health & Dermatology Summit aims to accelerate the development and commercialization of scientifically validated skin microbiome products. With the advancements in tools and technologies that allow for a deeper analysis of the skin microbiome, researchers are gaining a better understanding of this complex ecosystem. As a result, breakthrough dermatological, skincare, and cosmetic solutions are being developed to tap into the microbial network on our skin for improved health.However, there are still unique challenges that need to be addressed before microbiome skin products can be brought into the mainstream. The summit, taking place in September 2023, brings together over 80 key decision makers across 3 days to address the scientific R&D and consumer interfacing aspects of this industry. Through presentations, panel discussions, and networking opportunities, the summit aims to accelerate the development of microbiome-targeting therapeutics and cosmetics. This includes focusing on characterization, clinical testing, product commercialization, and claim substantiation to bring these products to patients and consumers faster.
Deep dive into the fascinating field of microbiome dermatology
Expand your knowledge through expert-led presentations, scientific debates, and case studies. Gain a deeper understanding of the interplay between the skin microbiome and dermatological conditions.
Explore about the development of microbiome-targeting therapeutics and cosmetics through a series of presentations, panel discussions, and networking opportunities.
Advancements across the tools and technologies used to increase our understanding of the skin microbiome are propelling the industry forwards.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Boston Analytical, the Life Sciences Division of Alpha Analytical, is a premier cGMP compliant, FDA & DEA registered, ISO Certified, pharmaceutical testing laboratory serving some of the most trusted institutional names worldwide.
CosmosID provides an end-to-end microbiome platform and award-winning metagenomics services.
Therapeutics Inc. is a drug research and development company focusing on integration of clinical and regulatory strategies, trial design, product development, and marketplace analysis.
The BioArte is an innovative player in the field of biomolecular research, highly specialized in researching the human microbiota and microbial communities in other environments. The aim of our diagnostic analyses is towards all types of microorganis
The BioArte is an innovative player in the field of biomolecular research, highly specialized in researching the human microbiota and microbial communities in other environments. The aim of our diagnostic analyses is towards all types of microorganisms, ranging from those which are essential for our
We currently market three strains of probiotic bacteria: BLIS K12™, BLIS M18™ and BLIS Q24®. BLIS K12™ and BLIS M18™ are both strains of Streptococcus salivarius, and occur naturally in the oral cavity. However, only around 2% of the population have
We currently market three strains of probiotic bacteria: BLIS K12™, BLIS M18™ and BLIS Q24®. BLIS K12™ and BLIS M18™ are both strains of Streptococcus salivarius, and occur naturally in the oral cavity. However, only around 2% of the population have these healthy bacteria at levels high enough to b
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.